SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG 2006; 113: 1742.
  • 2
    To MS, Skentou CA, Royston P, Yu CKH, Nicolaides KH. Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study. Ultrasound Obstet Gynecol 2006; 27: 362367.
  • 3
    Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462469.
  • 4
    DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall D, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, VanBuren G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW. Vaginal progesterone is associated with a decreased risk of early preterm birth and improved neonatal outcome in women with a short cervix. Ultrasound Obstet Gynecol 2007; 30: 697705.
  • 5
    Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 2007; 196: 453.e1453.e4.
  • 6
    Xu H, Gonzalez JM, Ofori E, Elovitz MA. Preventing cervical ripening: the primary mechanism by which progestional agents prevent preterm birth? Am J Obstet Gynecol 2008; 198: 314.e1314.e8.
  • 7
    Marx SG, Wentz MJ, Mackay LB, Schlembach D, Maul H, Fittkow C, Given R, Vedernikov Y, Saade GR, Garfield RE. Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix. J Histochem Cytochem 2006; 5: 623639.
  • 8
    Stys SJ, Clewell WH, Meschia G. Changes in cervical compliance at parturition independent of uterine activity. Am J Obstet Gynecol 1978; 130: 414418.
  • 9
    Hegele-Hartung C, Chwalisz K, Beier HM, Elger W. Ripening of the uterine cervix of the guinea-pig after treatment with the progesterone antagonist onapristone (ZK 98.299): an electron microscopic study. Hum Reprod 1989; 4: 369377.
  • 10
    Hein M, Petersen AC, Helmig RB, Uldbjerg N, Reinholdt J. Immunoglobin levels and phagocytes in the cervical mucus plug at term of pregnancy. Acta Obstet Gynecol Scand 2005; 84: 734742.
  • 11
    da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419424.
  • 12
    Sfakianaki AK, Norwitz ER. Mechanisms of progesterone action inhibiting prematurity. J Matern Fetal Neonatal Med 2006; 19: 763772.
  • 13
    Ruddock N, Shi SQ, Jain S, Moore G, Hankins GDV, Romero R, Garfield R. Progesterone (P4), but not 17 alpha hydroxyprogesterone caproate (17P), inhibits human myometrial contractions. Am J Obstet Gynecol 2008; 199: 391.e1391.e7.
  • 14
    Hardy DB, Janowski BA, Corey DR, Mendelson CR. Progesterone receptor plays a major anti-inflammatory role in human myometrial cells by antagonism of nuclear factor kappaB activation of cyclooxygenase 2 expression. Mol Endocrinol 2006; 20: 27242733.
  • 15
    Cakmak H, Schatz F, Huang ST, Buchwalder L, Rahman M, Arici A, Lockwood CJ. Progestin suppresses thrombin- and interleukin-1beta-induced interleukin-11 production in term decidual cells: implications for preterm delivery. J Clin Endocrinol Metab 2005; 90: 52795286.
  • 16
    Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the ‘functional progesterone withdrawal’. Mol Hum Reprod 2001; 7: 581586.
  • 17
    Murtha AP, Feng L, Yonish B, Leppert PC, Schomberg DW. Progesterone protects fetal chorion and maternal deciduas cells from calcium-induced death. Am J Obstet Gynecol 2007; 196: 257.e1257.e5.
  • 18
    Karalis K, Goodwin G, Majzoub JA. Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nat Med 1996; 2: 556560.
  • 19
    Jeschke U, Mylonas I, Richter DU, Hocker I, Briese V, Makrigiannakis A, Friese K. Regulation of progesterone production in human term trophoblasts in vitro by CRH, ACTH, and cortisol (prednisolone). Arch Gynecol Obstet 2005; 272: 712.
  • 20
    Klebanoff MA, Meis PJ, Dombrowski MP, Zhao Y, Moawad AH, Northen A, Sibai BM, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Leveno KJ, Miodovnik M, Conway D, Wapner RJ, Carpenter M, Mercer BM, Ramin SM, Thorp JM, Peaceman AM, for the NICHD MFMU. Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo. Am J Obstet Gynecol 2008; 199: 506.e1506.e7.
  • 21
    Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000; 21: 514550.
  • 22
    O'Brien JM, Adair CD, Lewis DF, Hall D, DeFranco EA, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, VanBuren G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007; 30: 687696.
  • 23
    Owen J, Yost N, Berghella V, Thom E, Swain M, Dildy GA 3rd, Miodovnik M, Langer O, Sibai B, McNellis D, NICHD MFMU. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 2001; 286: 13401348.
  • 24
    Uldberg N, Ekman G, Malmstrom A. Ripening of the human uterine cervix related to changes in collagen, glycosaminoglycans and collagenolytic activity. Am J Obstet Gynecol 1983; 147: 662666.
  • 25
    Bukowski R, Hankins GD, Saade GR, Anderson GD, Thornton S. Labor-associated gene expression in the human uterine fundus, lower segment, and cervix. PloS Med 2006; 3: e169.
  • 26
    Nicolaides KH. Some thoughts on the true value of ultrasound. Ultrasound Obstet Gynecol 2007; 30: 671674.
  • 27
    Romero R. Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment. Ultrasound Obstet Gynecol 2007; 30: 675686.